Alphatec Holdings (NASDAQ:
ATEC) initiated with Overweight rating and $7 (46% upside) price target at Piper Jaffray.
Healthcare Trust (NYSE:
HTA) upgraded to Outperform with a $30 (11% upside) price target at SMBC Nikko.
GlycoMimetics (NASDAQ:
GLYC) downgraded to Hold with a $6 (34% downside risk) price target at Jefferies after its lead drug
failed a late-stage study. Downgraded to Hold at SunTrust and Neutral at Piper. Shares down
52% premarket.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.